OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 1 filers reported holding OHR PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -92.9% | 4,000 | -50.0% | 0.00% | – |
| Q4 2017 | $14,000 | +366.7% | 8,000 | +100.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -50.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -45.5% | 4,000 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | -15.4% | 4,000 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | -48.0% | 4,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $25,000 | +13.6% | 4,000 | -48.7% | 0.00% | 0.0% |
| Q3 2015 | $22,000 | +10.0% | 7,800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $20,000 | – | 7,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 93,400 | $258,000 | 0.28% |
| Knoll Capital Management, LLC | 205,000 | $566,000 | 0.24% |
| Leisure Capital Management | 66,596 | $184,000 | 0.20% |
| Hoxton Financial, Inc. | 86,422 | $239,000 | 0.11% |
| Cutter & CO Brokerage, Inc. | 53,275 | $147,000 | 0.07% |
| Beech Hill Advisors, Inc. | 33,930 | $94,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 127,530 | $352,000 | 0.05% |
| Edge Wealth Management LLC | 24,000 | $66,000 | 0.02% |
| FineMark National Bank & Trust | 52,589 | $145,000 | 0.02% |
| BEACH INVESTMENT COUNSEL INC/PA | 51,872 | $143,000 | 0.02% |